Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life-Years for 32 Cancer Groups, Global Burden of Disease Cancer, vol.3, pp.524-548, 1990. ,
Clinical Use of Biomarkers in Breast Cancer: Updated Guidelines from the European Group on Tumor Markers (Egtm), Eur. J. Cancer, vol.75, pp.284-298, 2017. ,
Aryl Hydrocarbon Receptor Ligands in Cancer: Friend and Foe, Nat. Rev. Cancer, vol.14, pp.801-814, 2014. ,
Bhlh-Pas Proteins in Cancer, Nat. Rev. Cancer, vol.13, pp.827-841, 2013. ,
Antioxidant Functions of the Aryl Hydrocarbon Receptor, Stem Cells Int, vol.7943495, 2016. ,
Differential Recruitment of Coactivator Rip140 by Ah and Estrogen Receptors. Absence of a Role for Lxxll Motifs, J. Biol. Chem, vol.274, pp.22155-22164, 1999. ,
Transcriptional Regulation of the Human Nrip1/Rip140 Gene by Estrogen Is Modulated by Dioxin Signalling, Mol. Pharmacol, vol.69, pp.1338-1346, 2006. ,
Role of the Aryl Hydrocarbon Receptor in Carcinogenesis and Potential as an Anti-Cancer Drug Target, Arch. Toxicol, vol.91, pp.2497-2513, 2017. ,
Aryl Hydrocarbon Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells Via a Functional Interaction with Cyclin-Dependent Kinase 4, Mol. Pharmacol, vol.77, pp.195-201, 2010. ,
Expression of Aryl Hydrocarbon Receptor in Relation to P53 Status and Clinicopathological Parameters in Breast Cancer, Int. J. Clin. Exp. Pathol, vol.7, pp.7931-7937, 2014. ,
High Ahr Expression in Breast Tumors Correlates with Expression of Genes from Several Signaling Pathways Namely Inflammation and Endogenous Tryptophan Metabolism, PLoS ONE, vol.13, p.190619, 2018. ,
, Int. J. Mol. Sci, vol.20, p.1016, 2019.
The Aryl Hydrocarbon Receptor Mediates Raloxifene-Induced Apoptosis in Estrogen Receptor-Negative Hepatoma and Breast Cancer Cells, Cell Death Dis, vol.5, 1038. ,
The Aryl Hydrocarbon Receptor: A Target for Breast Cancer Therapy, J. Cancer Ther, vol.4, pp.1177-1186, 2013. ,
Strong Correlation between N-Cadherin and Cd133 in Breast Cancer: Role of Both Markers in Metastatic Events, J. Cancer Res. Clin. Oncol, vol.140, pp.1873-1881, 2014. ,
Correlation of Thyroid Hormone, Retinoid X, Peroxisome Proliferator-Activated, Vitamin D and Oestrogen/Progesterone Receptors in Breast Carcinoma, Oncol. Lett, vol.4, pp.665-671, 2012. ,
Thyroid Hormone Receptor (Tr)Alpha and Trbeta Expression in Breast Cancer, Histol. Histopathol, vol.28, pp.227-237, 2013. ,
Importance of Rip140 and Lcor Sub-Cellular Localization for Their Association with Breast Cancer Aggressiveness and Patient Survival, Transl. Oncol, vol.11, pp.1090-1096, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02292304
Recommendation for Uniform Definition of an Immunoreactive Score (Irs) for Immunohistochemical Estrogen Receptor Detection (Er-Ica) in Breast Cancer Tissue, Pathologe, vol.8, pp.138-140, 1987. ,
Aryl Hydrocarbon Receptor in Breast Cancer-a Newly Defined Prognostic Marker, Horm. Cancer, vol.5, pp.11-21, 2014. ,
Expression of the Aryl Hydrocarbon Receptor/Transcription Factor (Ahr) and Ahr-Regulated Cyp1 Gene Transcripts in a Rat Model of Mammary Tumorigenesis, Breast Cancer Res. Treat, vol.63, pp.117-131, 2000. ,
Nuclear Localization and Export Signals of the Human Aryl Hydrocarbon Receptor, J. Biol. Chem, vol.273, pp.2895-2904, 1998. ,
Nucleocytoplasmic Shuttling of the Aryl Hydrocarbon Receptor, J. Biochem, vol.127, pp.503-509, 2000. ,
Characterization of the Lxxll Motif in the Aryl Hydrocarbon Receptor: Effects on Subcellular Localization and Transcriptional Activity, J. Biochem, vol.131, pp.79-85, 2002. ,
The Expression Level of the Transcription Factor Aryl Hydrocarbon Receptor Nuclear Translocator (Arnt) Determines Cellular Survival after Radiation Treatment, Radiat. Oncol, vol.10, p.229, 2015. ,
A Molecular Mechanism to Switch the Aryl Hydrocarbon Receptor from a Transcription Factor to an E3 Ubiquitin Ligase, Mol. Cell Biol, vol.37, pp.630-646, 2017. ,
Cytoplasmic Aryl Hydrocarbon Receptor Regulates Glycogen Synthase Kinase 3 Beta, Accelerates Vimentin Degradation, and Suppresses Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer Cells, Arch. Toxicol, vol.91, pp.2165-2178, 2017. ,
Prognostic Impact of Proteolytic Factors (Urokinase-Type Plasminogen Activator, Plasminogen Activator Inhibitor 1, and Cathepsins B, D, and L) in Primary Breast Cancer Reflects Effects of Adjuvant Systemic Therapy, Clin. Cancer Res, vol.7, pp.2757-2764, 2001. ,
Aryl Hydrocarbon Receptor Modulation of Estrogen Receptor Alpha-Mediated Gene Regulation by a Multimeric Chromatin Complex Involving the Two Receptors and the Coregulator Rip140, Toxicol. Sci, vol.125, pp.401-411, 2012. ,
Standard and Genomic Tools for Decision Support in Breast Cancer Treatment, Am. Soc. Clin. Oncol, vol.37, pp.106-115, 2017. ,
A Role for the Aryl Hydrocarbon Receptor in Mammary Gland Tumorigenesis, Biol. Chem, vol.387, pp.1175-1187, 2006. ,
An Online Survival Analysis Tool to Rapidly Assess the Effect of 22,277 Genes on Breast Cancer Prognosis Using Microarray Data of 1,809 Patients, Breast Cancer Res. Treat, vol.123, pp.725-731, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00520003
Breastmark: An Integrated Approach to Mining Publicly Available Transcriptomic Datasets Relating to Breast Cancer Outcome, Breast Cancer Res, vol.15, 2013. ,
Method for Grading Breast Cancer, J. Clin. Pathol, vol.46, pp.189-190, 1993. ,
Multicentric and Multifocal Versus Unifocal Breast Cancer: Differences in the Expression of E-Cadherin Suggest Differences in Tumor Biology, BMC Cancer, vol.13, 2013. ,
Expression of Her2/Neu, Steroid Receptors (Er and Pr), Ki67 and P53 in Invasive Mammary Ductal Carcinoma Associated with Ductal Carcinoma in Situ (Dcis) Versus Invasive Breast Cancer Alone, Anticancer Res, vol.25, pp.1719-1723, 2005. ,